Expert Outlook: Amicus Therapeutics Through The Eyes Of 4 Analysts
Expert Outlook: Amicus Therapeutics Through The Eyes Of 4 Analysts
專家展望：愛美醫療在4位分析師眼中
The analysis of recent analyst actions sheds light on the perception of Amicus...In the latest quarter, 4 analysts provided ratings for Amicus Therapeutics (NASDAQ:FOLD), showcasing a mix of bullish and bearish perspectives.
在最新的季度中，4位分析師爲愛美醫療（納斯達克:FOLD）提供了評級，展示了積極和悲觀的觀點。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表總結了他們最近的評級，展示了過去30天內不斷變化的情緒，並將其與前幾個月進行了比較。
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $18.0, a high estimate of $20.00, and a low estimate of $16.00. This current average has decreased by 3.59% from the previous average price target of $18.67.
分析師通過對12個月價格目標的評估提供更深入的見解，顯示平均目標爲$18.0，高估爲$20.00，低估爲$16.00。當前平均值比之前的$18.67的平均價格目標下降了3.59%。
Exploring Analyst Ratings: An In-Depth Overview
分析師評級:深入了解
The analysis of recent analyst actions sheds light on the perception of Amicus...
最近分析師行動的分析揭示了...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間